- Home
- TEM
TEM
TEMPUS AI INC
as 12-18-2024 10:43am EST
Stocks
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 9.9B | IPO Year: | 2024 |
| Target Price: | $56.80 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $22.89 - $79.49 | Next Earning Date: | 02-17-2025 |
| Revenue: | $640,442,000 | Revenue Growth: | 32.13% |
| Revenue Growth (this year): | 32.77% | Revenue Growth (next year): | 29.83% |
Stock Insider Trading Activity of TEMPUS AI INC (TEM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Leonsis Theodore | TEM | Director | Dec 11 '24 | Sell | $41.17 | 400,000 | $16,494,839.63 | 3,260,948 | |
| Doudna Jennifer A | TEM | Director | Dec 11 '24 | Sell | $41.81 | 1,183 | $49,461.23 | 37,331 | |
| Fukushima Ryan | TEM | Chief Operating Officer | Dec 11 '24 | Sell | $42.28 | 120,000 | $5,101,727.82 | 1,084,205 | |
| Phelps Erik | TEM | EVP & Chief Admin & Legal Off | Dec 11 '24 | Sell | $42.65 | 92,373 | $3,940,474.74 | 308,426 | |
| Epstein David R | TEM | Director | Dec 11 '24 | Sell | $41.81 | 620 | $25,922.20 | 27,894 | |
| Red Sky Ventures LLC | TEM | 10% Owner | Dec 11 '24 | Sell | $40.88 | 1,950,000 | $79,762,500.00 | 14,610,249 | |
| Polovin Andrew | TEM | EVP and General Counsel | Dec 11 '24 | Sell | $42.30 | 51,504 | $2,183,186.68 | 293,689 |
Latest TEMPUS AI INC News
TEM Breaking Stock News: Dive into TEM Ticker-Specific Updates for Smart Investing
MT Newswires
2 hours ago
Tempus Signs In-Network Contracts With Blue Cross Blue Shield of Illinois, California, Avalon Healthcare Solutions
Business Wire
3 hours ago
Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare Solutions
Insider Monkey
8 hours ago
Tempus AI, Inc (TEM) Expands Partnership with Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma
Business Wire
a day ago
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
Investor's Business Daily
2 days ago
Stock Market Today: Dow Jones Dips As Warren Buffett Play Eyes Entry; Cathie Wood Loads Up On This AI Stock Amid 48% Plunge
The Wall Street Journal
2 days ago
Trump and SoftBank CEO Unveil $100 Billion Investment in U.S.
MT Newswires
2 days ago
Personalis, Tempus AI Expand Collaboration to Biopharma Industry
The Wall Street Journal
2 days ago
Trump, SoftBank CEO to Announce $100 Billion Investment in U.S.
Compare TEM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TEM TEMPUS AI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.